Survival Outcomes in Patients with Hormone Receptor-Positive Metastatic Breast Cancer with Low or No ERBB2 Expression Treated with Targeted Therapies Plus Endocrine Therapy

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Survival Outcomes in Patients with Hormone Receptor-Positive Metastatic Breast Cancer with Low or No ERBB2 Expression Treated with Targeted Therapies Plus Endocrine Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences